Oncoinvent (Acquired) Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 45

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 11

Oncoinvent (Acquired) General Information

Description

Developer of pharmaceutical products intended to serve the healthcare sector. The company's main product candidate, Radspherin, is currently in clinical development in two indications: peritoneal metastasis from ovarian and colorectal cancer, but is also relevant for treating peritoneal metastasis from other cancer types and potentially metastatic cancer in other body cavities.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly PE-Backed
Corporate Office
  • Gullhaugveien 7
  • 0484 Oslo
  • Norway
+47 22
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Parent Company
Oncoinvent
Vertical(s)
Life Sciences, Oncology
Former Stock Listing
ONCIN
Corporate Office
  • Gullhaugveien 7
  • 0484 Oslo
  • Norway
+47 22

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Oncoinvent (Acquired) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Oncoinvent (Acquired)‘s full profile, request access.

Request a free trial

Oncoinvent (Acquired) Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of pharmaceutical products intended to serve the healthcare sector. The company's main product candidate, Rads
Drug Discovery
Oslo, Norway
45 As of 2026

Framingham, MA
 

Seal Beach, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Oncoinvent (Acquired) Competitors (68)

One of Oncoinvent (Acquired)’s 68 competitors is Xenetic Biosciences, a Corporation company based in Framingham, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Xenetic Biosciences Corporation Framingham, MA
Dendreon Formerly VC-backed Seal Beach, CA
CytoAgents Venture Capital-Backed Pittsburgh, PA
Ayala Pharmaceuticals Corporation Wilmington, DE
Geron Formerly VC-backed Foster City, CA
You’re viewing 5 of 68 competitors. Get the full list »

Oncoinvent (Acquired) Patents

  • 21

    Total Documents Applications and Grants

  • Total Patents Families

  • 10

    Granted

  • 2

    Pending

  • Expiring in next 12 mo

Oncoinvent (Acquired) Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025040588-A1 Monoclonal anti-ptk7 antibodies and derivatives Inactive 18-Aug-2023
WO-2024146921-A1 Alpha-emitting radionuclides for use in the treatment of peritoneal cancer Inactive 05-Jan-2023
CA-3192409-A1 Preparations of radium-224 and progenies for use in radionuclide therapy in combination with dna repair inhibitors Pending 15-Sep-2020
WO-2022058338-A1 Preparations of radium-224 and progenies for use in radionuclide therapy in combination with dna repair inhibitors Inactive 15-Sep-2020
CA-3192423-A1 Size controlled radiolabelled particles Pending 15-Sep-2020 A61K51/1244
To view Oncoinvent (Acquired)’s complete patent history, request access »

Oncoinvent (Acquired) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Oncoinvent (Acquired) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Oncoinvent (Acquired)‘s full profile, request access.

Request a free trial

Oncoinvent (Acquired) FAQs

  • When was Oncoinvent (Acquired) founded?

    Oncoinvent (Acquired) was founded in 2010.

  • Where is Oncoinvent (Acquired) headquartered?

    Oncoinvent (Acquired) is headquartered in Oslo, Norway.

  • What is the size of Oncoinvent (Acquired)?

    Oncoinvent (Acquired) has 45 total employees.

  • What industry is Oncoinvent (Acquired) in?

    Oncoinvent (Acquired)’s primary industry is Drug Discovery.

  • Is Oncoinvent (Acquired) a private or public company?

    Oncoinvent (Acquired) is a Private company.

  • What is Oncoinvent (Acquired)’s current revenue?

    The current revenue for Oncoinvent (Acquired) is .

  • How much funding has Oncoinvent (Acquired) raised over time?

    Oncoinvent (Acquired) has raised $96.2M.

  • Who are Oncoinvent (Acquired)’s investors?

    Artal, Birk Venture, Canica, Farvatn Venture, and Geveran Trading are 5 of 15 investors who have invested in Oncoinvent (Acquired).

  • Who are Oncoinvent (Acquired)’s competitors?

    Xenetic Biosciences, Dendreon, CytoAgents, Ayala Pharmaceuticals, and Geron are some of the 68 competitors of Oncoinvent (Acquired).

  • When was Oncoinvent (Acquired) acquired?

    Oncoinvent (Acquired) was acquired on 29-Oct-2025.

  • Who acquired Oncoinvent (Acquired)?

    Oncoinvent (Acquired) was acquired by Oncoinvent.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process